Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Sho Nakamura, Tadahisa Fukui, Shuhei Suzuki, Hiroyuki Takeda, Kaname Watanabe, Takashi Yoshioka Department of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan Abstract: Bone marrow metastasis is a rare consequence of colorectal cancer that results in a poor prognosis; fe...

Full description

Bibliographic Details
Main Authors: Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
colorectal cancer
anti-epidermal growth factor receptor antibody
molecular targeted therapies
disseminated intravascular coagulation
standard of care.
Online Access:https://www.dovepress.com/long-term-survival-after-a-favorable-response-to-anti-egfr-antibody-pl-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/long-term-survival-after-a-favorable-response-to-anti-egfr-antibody-pl-peer-reviewed-article-OTT

Similar Items